Search Results - "YASUGI, T."

Phase III randomised controlled trial of neoadjuvant chemotherapy plus radical surgery vs radical surgery alone for stages IB2, IIA2, and IIB cervical cancer: a Japan Clinical Oncology Group trial (JCOG 0102) by Katsumata, N, Yoshikawa, H, Kobayashi, H, Saito, T, Kuzuya, K, Nakanishi, T, Yasugi, T, Yaegashi, N, Yokota, H, Kodama, S, Mizunoe, T, Hiura, M, Kasamatsu, T, Shibata, T, Kamura, T

“…Background: A phase III trial was conducted to determine whether neoadjuvant chemotherapy (NACT) before radical surgery (RS) improves overall survival…”
Get full text

Secondary cytoreductive surgery for recurrent epithelial ovarian carcinoma: proposal for patients selection by Onda, T, Yoshikawa, H, Yasugi, T, Yamada, M, Matsumoto, K, Taketani, Y

“…The value of secondary cytoreductive surgery (SCS) for recurrent ovarian cancer is still controversial. The aim of this study was to clarify candidates for…”
Get full text

Analysis of the expression and localisation of a LAP protein, human scribble, in the normal and neoplastic epithelium of uterine cervix by NAKAGAWA, S, YANO, T, NAKAGAWA, K, TAKIZAWA, S, SUZUKI, Y, YASUGI, T, HUIBREGTSE, J. M, TAKETANI, Y

“…Recently, a LAP protein, scribble, was identified in Drosophila epithelia as a basolateral protein that controls the apical-basolateral polarity. Loss of…”
Get full text

Genome-wide cDNA microarray analysis of gene-expression profiles involved in ovarian endometriosis by Arimoto, Takahide, Katagiri, Toyomasa, Oda, Katsutoshi, Tsunoda, Tatsuhiko, Yasugi, Toshiharu, Osuga, Yutaka, Yoshikawa, Hiroyuki, Nishii, Osamu, Yano, Tetsu, Taketani, Yuji, Nakamura, Yusuke

“…Using a cDNA microarray consisting of 23,040 genes, we analyzed gene-expression profiles of ovarian endometrial cysts from 23 patients in order to identify…”
Get more information

EP-1149 CLINICAL RESULTS IN RADIOTHERAPY ALONE OR CHEMORADIOTHERAPY FOR SQUAMAOUS CELL CARCINOMA OF THE UTERINE CERVIX by Chang, T, Karasawa, K, Hanyu, N, Mizutani, K, Ozaki, Y, Yasugi, T, Taniguchi, Y, Kino, N

Get full text

The Optimal Debulking after Neoadjuvant Chemotherapy in Ovarian Cancer: Proposal Based on Interval Look During Upfront Surgery Setting Treatment by Onda, Takashi, Yoshikawa, Hiroyuki, Yasugi, Toshiharu, Matsumoto, Koji, Taketani, Yuji

“…Objective The optimal goal of interval debulking surgery (IDS) following neoadjuvant chemotherapy (NAC) remains undefined. The aim of this study was to…”
Get full text

The DNA mismatch repair gene hMSH2 is a potent coactivator of oestrogen receptor α by WADA-HIRAIKE, O, YANO, T, KATO, S, TAKETANI, Y, NEI, T, MATSUMOTO, Y, NAGASAKA, K, TAKIZAWA, S, OISHI, H, ARIMOTO, T, NAKAGAWA, S, YASUGI, T

“…The DNA mismatch repair gene is a key regulator in the elimination of base-base mismatches and insertion/deletion loops (IDLs). Human MutS homologue 2 (hMSH2),…”
Get full text

Prevalence of ovarian endometriosis in epithelial ovarian cancer by Jimbo, H, Yoshikawa, H, Onda, T, Yasugi, T, Sakamoto, A, Taketani, Y

“…Objective: The objective of this study was to examine the occurrence of ovarian endometriosis in epithelial ovarian cancer in Japan. Method: The presence of…”
Get full text

PTEN Mutation Located Only Outside Exons 5, 6, and 7 Is an Independent Predictor of Favorable Survival in Endometrial Carcinomas by MINAGUCHI, Takeo, YOSHIKAWA, Hiroyuki, ODA, Katsutoshi, ISHINO, Tomomi, YASUGI, Toshiharu, ONDA, Takashi, NAKAGAWA, Shunsuke, MATSUMOTO, Koji, KAWANA, Kei, TAKETANI, Yuji

“…Although the prognostic impact of PTEN mutation in endometrial carcinoma is beginning to be analyzed, the prognostic significance of mutated PTEN exons has not…”
Get full text

Three-year cardiovascular events and disease progress in patients with peripheral arterial disease: results from the Japan Medication Therapy for Peripheral Arterial Disease (J-METHOD) by Shigematsu, H, Nishibe, T, Obitsu, Y, Matsuzaki, K, Ishida, A, Miyata, T, Shindo, S, Hida, K, Ohta, T, Ando, M, Kawasaki, T, Yasugi, T, Matsumoto, T

“…To investigate the current status of peripheral arterial disease (PAD) drug treatment in Japan, and the effects of drug treatment, risk factors, and…”
Get more information

OP-067: TRANSIENT ISCHEMIA-INDUCED PARESIS AND PARALYSIS DISPLAYED DISTINCT REACTIONS OF MICROGLIA AND MACROPHAGES by Nakata, T, Kawachi, K, Nagashima, M, Yasugi, T, Izutani, H, Ryugo, M, Shikata, F, Okamura, T, Tanaka, J, Yano, H, Takahashi, H

Get full text

Are smoking and chlamydial infection risk factors for CIN? Different results after adjustment for HPV DNA and antibodies by Matsumoto, K, Yasugi, T, Oki, A, Hoshiai, H, Taketani, Y, Kawana, T, Yoshikawa, H

“…To identify the risk factors for cervical intraepithelial neoplasia (CIN), we reanalysed the data from our previous case-control study by adjusting for human…”
Get full text

3-D fractal tumor growth of epithelial ovarian cancer by Kikuchi, A, Kozuma, S, Yasugi, T, Taketani, Y

“…A fractal is a shape made of parts similar to the whole. Our objective was to determine whether surface growth patterns in malignant epithelial ovarian tumors…”
Get more information

Targeted mutagenesis of the human papillomavirus type 16 E2 transactivation domain reveals separable transcriptional activation and DNA replication functions by Sakai, H, Yasugi, T, Benson, J D, Dowhanick, J J, Howley, P M

“…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text

Abnormal Fhit expression is an independent poor prognostic factor for cervical cancer by TAKIZAWA, S, NAKAGAWA, S, NAKAGAWA, K, YASUGI, T, FUJII, T, KUGU, K, YANO, T, YOSHIKAWA, H, TAKETANI, Y

“…We analysed the expression of the fragile histidine triad (FHIT) gene in cervical cancer to evaluate its clinical relevance in relation to human papillomavirus…”
Get full text

Mapping and characterization of the interaction domains of human papillomavirus type 16 E1 and E2 proteins by Yasugi, T, Benson, J D, Sakai, H, Vidal, M, Howley, P M

“…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text

Occurrence of C3 nephritic factor and C4 nephritic factor in membranoproliferative glomerulonephritis (MPGN) by OHI, H., YASUGI, T.

“…SUMMARY One hundred patents diagnosed with hypocomplementaemic MPGN (C3<40%) were studied to determine the presence of C3 nephritic factor (C3NeF) and/or C4…”
Get full text

PO-1431 A phase I/II study of SBRT boost in patients with cervical cancer who are ineligible for ICBT by Ito, K., Nakajima, Y., Ogawa, H., Furusawa, A., Murofushi, K., Kito, S., Kino, N., Yasugi, T., Uno, T., Karasawa, K.

Get full text

Assessment of para‐aortic lymph nodes by intraoperative sonography in gynecological malignancies: a preliminary report by Ryo, E., Nagasaka, T., Yasugi, T., Kozuma, S., Taketani, Y.

“…Objective To investigate the usefulness of intraoperative sonography for the assessment of para‐aortic lymph nodes in gynecological malignancies. Methods The…”
Get full text

Two classes of human papillomavirus type 16 E1 mutants suggest pleiotropic conformational constraints affecting E1 multimerization, E2 interaction, and interaction with cellular proteins by Yasugi, T, Vidal, M, Sakai, H, Howley, P M, Benson, J D

“…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text